Browsing: biotech

Dimension, a venture firm specializing in the intersection of life science and technology, has announced a $500 million fund, Dimension II, building on its initial $350 million fund.

A roundup of the top 10 venture funding deals exceeding $100 million in the U.S. showcasing strong investment in space technology, biotechnology, and cybersecurity.

A look at the top 10 venture capital deals in the U.S. from the week of January 11-17, 2025, featuring companies in biotech, space, and more.

A look at recent investments and developments in the artificial intelligence startup space, including funding rounds for robotics and biotech companies, as well as new initiatives in open-source AI and venture capital.

Eikon Therapeutics, a drug discovery startup, secured significant funding to advance its cancer therapy pipeline.

Koneksa Health is leveraging the popularity of GLP-1 drugs to study their potential in treating Parkinson’s disease, following promising preliminary research.

Miami is rapidly becoming a leading hub for healthtech innovation, with startups addressing healthcare challenges and pioneering new technologies.

Dimension, a biotech venture firm, has secured a $500 million fund to invest in companies at the intersection of life science and technology, focusing on tech-powered therapeutics and drug discovery tools.